Stephan R Vavricka
Overview
Explore the profile of Stephan R Vavricka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
6334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cozzi G, Scagnellato L, Lorenzin M, Savarino E, Zingone F, Ometto F, et al.
Nat Rev Rheumatol
. 2023 Jun;
19(8):503-518.
PMID: 37386288
Spondyloarthritis (SpA) encompasses a heterogeneous group of chronic inflammatory diseases that can affect both axial and peripheral joints, tendons and entheses. Among the extra-articular manifestations, inflammatory bowel disease (IBD) is...
12.
Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, et al.
J Crohns Colitis
. 2023 Jun;
18(1):1-37.
PMID: 37351850
No abstract available.
13.
von Graffenried T, Schoepfer A, Rossel J, Greuter T, Safroneeva E, Godat S, et al.
JPGN Rep
. 2023 May;
3(2):e193.
PMID: 37168919
Methods: Prospective analysis of pediatric IBD patients. Patients were categorized into 4 groups according to the World Health Organization (WHO) child growth standards: obese, overweight, normal weight, and underweight. Results:...
14.
Kopylov U, Burisch J, Ben-Horin S, Braegger F, Fernandez-Nistal A, Lara N, et al.
Inflamm Bowel Dis
. 2023 May;
29(11):1713-1722.
PMID: 37158585
Background: Patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, may develop extraintestinal manifestations (EIMs). The EMOTIVE study aimed to analyze the effect of vedolizumab on EIMs...
15.
Podmore B, Beier D, Burisch J, Genestin E, Haeckl D, Nagel O, et al.
United European Gastroenterol J
. 2023 May;
11(6):520-530.
PMID: 37140403
Background: Patients with inflammatory bowel disease are at increased risk of colorectal and extra-intestinal cancer. However, the overall cancer risk in patients with Crohn's disease (CD) with perianal fistulas (PF)...
16.
Albshesh A, Bannon L, Sharar Fischler T, Truyens M, Vavricka S, Tepes K, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048587
Background: The effectiveness of anti-TNF or ustekinumab (UST) as a second-line biologic after vedolizumab (VDZ) failure has not yet been described. Aims And Methods: In this retrospective multicenter cohort study,...
17.
Spalinger M, Kasper S, Gottier C, Lang S, Atrott K, Vavricka S, et al.
J Clin Invest
. 2023 Feb;
133(4).
PMID: 36787260
No abstract available.
18.
Gordon H, Biancone L, Fiorino G, Katsanos K, Kopylov U, Al Sulais E, et al.
J Crohns Colitis
. 2022 Dec;
17(6):827-854.
PMID: 36528797
No abstract available.
19.
Martinho-Grueber M, Kapoglou I, Bravo F, Sarraj R, Benz E, Restellini S, et al.
Eur J Gastroenterol Hepatol
. 2022 Nov;
35(1):21-30.
PMID: 36317770
Objectives Of The Study: There is little guidance regarding the impact of alcohol and cannabis on the clinical course of inflammatory bowel disease. The aim of this study was to...
20.
Vieujean S, Moens A, Hassid D, Rothfuss K, Savarino E, Vavricka S, et al.
J Crohns Colitis
. 2022 Oct;
17(4):472-479.
PMID: 36223253
Background And Aim: Pneumocystis jirovecii pneumonia [PJP] is a very rare, potentially life-threatening pulmonary fungal infection that occurs in immunocompromised individuals including patients with inflammatory bowel disease [IBD]. Our aim...